Viennese Prevalence Study of Anderson-Fabry Disease

NCT00871611 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2011-07-28

No results posted yet for this study

Summary

The prevalence of Anderson - Fabry disease in patients with left ventricular hypertrophy is unclear. The investigators will examine urine - α - Galactosidase activity and globotriaosylceramide isoforms in these patients.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER
  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Gerald Mundigler, MD · Medical University of Vienna, Dept. Internal Medicine, Cardiology

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00871611 on ClinicalTrials.gov